Trials / Completed
CompletedNCT00158379
Taxol Carboplatin and Erythropoetin
Carboplatin With Following Taxol® Therapy Under Additional Application of Epoetin Alfa (ERYPO ®) With Female Patients With Advanced Ovarian Cancer FIGO IA/G3 - IV
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 105 (actual)
- Sponsor
- North Eastern German Society of Gynaecological Oncology · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Time to progression (physical examination and radiologic imaging
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paclitaxel | 4 cycles of Carboplatin AUC 5 every 3 weeks. 12 weekly infusions of 80 mg/m² Taxol® |
Timeline
- Start date
- 2003-07-01
- Primary completion
- 2008-04-01
- Completion
- 2008-06-01
- First posted
- 2005-09-12
- Last updated
- 2017-02-06
- Results posted
- 2016-11-25
Source: ClinicalTrials.gov record NCT00158379. Inclusion in this directory is not an endorsement.